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Background: Studies regarding the physiological role of acidic mammalian chitinase (AMCase)
and the effects of its genetic variants on asthma have produced conflicting results.
Objectives: We aimed to determine the genetic variants in the AMCase gene that could regu-
late the gene expression and thus influence disease severity.
Methods: Genetic variants of the AMCase gene were determined by sequencing of asthmatics
and healthy controls in up to 1 kb in the promoter region and exon 1 and 2. In an association
study, a population of asthmatic (nZ 504) and healthy Turkish children (nZ 188) were geno-
typed for the observed SNPs. A replication study was performed in a North American adult po-
pulation of patients with mild (n Z 317) and severe (n Z 145) asthma. The functional
properties of the insertion were determined by promoter reporter assay, electromobility shift
assay and transcription factor ELISA experiments.
Results: Of the identified SNPs, only a ten base pair insertion (CAATCTAGGC) in the 50UTR
region of exon 2 was significantly associated with lower FEV1 (b Z 14.63 SE Z 6.241,
PZ 0.019) in Turkish children with asthma. However, in the adult population, the same inser-
tion showed a trend toward higher FEV1. The insertion was shown to have enhancer activity
and the mutant probe possessing the insertion had higher binding affinity for the nuclear
extracts.33 727 6459; fax: þ90 312 441 9555.
e.edu.tr (O¨. Kalayci).
1 Elsevier Ltd. All rights reserved.
Chitinase polymorphisms in asthma 1161Conclusion: Our study shows that a ten base pair insertion in the 50UTR region of AMCase gene
may modify gene expression and thus may affect the severity of asthma. However, its effects
appear to be different in different populations.
ª 2011 Elsevier Ltd. All rights reserved.Introduction
Chitin is the second most abundant polysaccharide in
nature after cellulose. It is found as a structural component
of many species such as exoskeleton of crustaceans, para-
sitic nematodes and walls of fungi. It protects these
organisms from harsh conditions.1e4 Chitinases are enzymes
that hydrolyze chitin and are part of the anti-parasitic
response against chitin containing organisms in lower life
forms. Although there is no chitin in humans, recent studies
have identified functional mammalian chitinase genes such
as chitotriosidase (CHIT1) and acidic mammalian chitinase
(AMCase, CHIA) and several chitinase-like genes such as
YKL-40 (CHI3L1).5e9
AMCase is one of the enzymes with true chitinase
activity.10 The gene is located on chromosome 1q13.1e21.3
and contains 12 exons which transcribes into a 50 kD
protein. The gene also encodes various splice forms. The
enzyme is acid stable and mostly expressed in the gastro-
intestinal tract and in the asthmatic lung.10 In their pio-
neering study, Zhu et al. showed that AMCase is expressed
in the epithelial cells and alveolar macrophages in patients
with asthma.11 In a murine model of asthma, they showed
that AMCase acts downstream of IL-13 driven cytokine
response. In support of this observation, Chupp et al. have
shown that serum levels of a chitinase-like protein, YKL-40,
were higher in asthmatics than control subjects and that
they correlated positively with the severity of asthma and
inversely with FEV1%.
12 The same group also showed that
a SNP in the promoter region of the gene encoding YKL-40
was associated with elevated serum YKL-40 levels, asthma,
bronchial hyper-responsiveness, and measures of pulmo-
nary functions.13
Even though many studies have suggested that AMCase is
a positive mediator of Th2 response,14 more recent studies
have challenged these findings. For example, Reese et al.
showed that in a mouse model, AMCase inhibits chitin
induced eosinophil and basophil recruitment to the lungs
suggesting that AMCase can prevent allergic response
induced by chitin.15 Similarly, in a human study, Seibold
et al. measured chitinase activity in bronchoalveolar lavage
(BAL) samples of asthmatics, habitual smokers and healthy
controls and found that chitinase activity in human BAL
samples was mostly related to chitotriosidase (CHIT1) but
not to AMCase.16 Furthermore, they showed that chitinase
activity was not higher, but actually lower in BAL fluids of
asthmatics than control subjects and was increased in
habitual smokers.gr1
Similar to the conflicting findings regarding its physiolog-
ical role in asthma, the studies on the effect of genetic
variants on disease and disease phenotypes have produced
some contradictory findings, as well. Bierbaum et al. iden-
tified six SNPs in the promoter and three SNPs in the exonic
region of AMCase and reported that a non-synonymous SNP,Lys17Arg, and possibly a promoter SNP (rs12033184), are
associated with pediatric asthma in a German population.17
In contrast, Seibold et al. could not detect the Lys17Arg
SNP in a population composed of adult African American,
Puerto Rican, and Mexicans.18 They genotyped this pop-
ulation for 8 SNPs in the coding region and reported that some
haplotypes composed of these SNPs are protective against
asthma and are in fact associated with increased levels of
chitinase activity in-vitro. Chatterjee et al. repeated Bier-
baum’s study in an Indian population by including a wider
region of promoter and 30UTR region.19 They reported quite
a different set of SNPs with only four being common in both
reports. In this report one promoter SNP, rs3806448, was
associated with both asthma and IgE; and another one,
rs10494132, was associated with IgE only. In a more recent
study, however, neither of these SNPs nor any of the 24 SNPs
analyzed was found to be associated with asthma or asthma
related phenotypes.20
In summary, similar to studies assessing associations with
physiological outcomes, the results of studies evaluating
genotypic associations of AMCase gene with asthma have
produced conflicting results. We aimed to search for
genetic variants in the AMCase gene that could regulate the
gene expression and thus may influence disease expression
in a case-control study involving Turkish children. For this
purpose, we sequenced the promoter region up to 1 kB
and also exon 1 and exon 2 as several different transcripts
of the gene have been shown to include different exons.
Here, we report our findings on the association of several
SNPs and a 10 base pair insertion in the 50UTR region of exon
2. We also attempted to replicate our findings with the 10
base pair insertion in a population composed of adult
asthmatics from the United States; and also determine the
functional properties of this insertion.Materials and methodsStudy population
Children with asthma: The patients in the asthma group
have been detailed previously.21e23 Briefly, we enrolled
children aged 6e18 years who were diagnosed with asthma
at the Pediatric Allergy and Asthma Unit of Hacettepe
University, School of Medicine, Ankara, Turkey between
2002 and 2009. Asthma diagnosis was confirmed by the
examining pediatric allergist according to GINA guide-
lines.24 All children had evidence of reversible airway
obstruction as defined by at least a 12% improvement in
FEV1% following bronchodilator administration, therapeutic
response to anti-asthma treatment, or an abnormal result
in methacholine bronchoprovocation test (PC20 < 8 mg/dl).
Spirometric measurements, total IgE, and eosinophil counts
were obtained. Skin testing was performed as detailed
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committee of Hacettepe University and the parents have
provided written informed consent for the study.
Healthy Children: The patients in the control group have
been detailed previously.23 Briefly, the control group was
composed of Turkish school children who presented
between 2005 and 2006 to the outpatient department of
the same hospital. They presented for reasons such as
minor trauma or for their regular follow-up. They respon-
ded negatively to an established and validated asthma
questionnaire (ISAAC),25 never had any diagnosis of asthma
or allergic bronchitis by a physician, and never had any
history of wheezing. They all had normal pulmonary func-
tion tests. All children underwent skin prick testing and had
their total IgE measured in serum.
Adults with asthma: To test whether the findings
observed in children with asthma could be replicated in an
adult asthma population, we genotyped adult asthmatics
from the USA composed of patients with mild and severe
asthma. 462 subjects classified as either mild or severe
asthmatics by the NAEPP guidelines were identified from
the Brigham and Women’s Hospital’s (BWH) Asthma
Research Center’s database. These patients were recruited
between 2001 and 2008, and each had signed a written
informed consent agreeing to exploratory genetic analysis
related to asthma, which was approved by the BHW insti-
tutional review board. Baseline demographic information
was available for each subject and baseline spirometry was
performed on the day of the blood draw. All the patients in
the adult population were non-smokers, defined as less
than or equal to 10 pack year smoking history and none in
the last 12 months. DNA was stored at the Channing Labo-
ratory where genotyping was performed for the 10 base pair
insertion (CAATCTAGGC) identified in the 50UTR region of
exon 2, as described below.
Identification of genetic variants
DNA was extracted from whole blood by standard tech-
niques. To determine the polymorphisms in the promoter
region and 50UTR region of the transcript including exon 1
and exon 2 of AMCase gene, DNA samples from 20 children
with asthma and 20 healthy children were sequenced with
Big Dye Terminator cycle sequencing kit (3.2 version) from
ABI Prism (Foster City, CA, USA). Sequencing of the
promoter and the first 2 exons revealed the presence of 10
SNPs, 8 in the promoter, 2 in exon 1 and a ten base pair
insertion in the 50UTR of Exon 2. According to the initial
analysis, 8 of the 10 SNPs, six SNPs in the promoter region
and two SNPs in Exon 1, seemed to be in linkage disequi-
librium. To prove this, 100 individuals were further
sequenced in the promoter region.
Genotyping of the promoter region
Sequencing of 100 samples showed that eight of the
promoters’ SNPs were in perfect linkage disequilibrium.
Therefore, we chose one of them, rs4442363 SNP, to
determine the genotype by restriction fragment length
polymorphism (RFLP) analysis. A 613 base pair of the
promoter region was amplified using the following primer
pairs: forward 50-CGGACACTGGACTTAAGTTGT-30 and
reverse 50-GAAGCTTTGGCACCGTCT-30. The amplicon was
digested with Hinf I (New England BioLabs, MA, USA) andthe products were fractionated on a 2% agarose gel.
Digestion occurs only in the presence of the T allele and
produces a 214 and 399 base pair products; whereas the
undigested C allele is visualized as a single 613 base pair
band. 10% of samples randomly selected but including from
all genotypes were re-genotyped for quality control.
Genotyping of the insertion at 50UTR region of exon 2
The genotyping for the 10 base pair insertion (CAATCTAGGC)
was again done by PCR-RFLP analysis. A 451 base pair
segment in the 50UTR region of exon 2was amplified using the
following primers: Forward 50-CTGACCACAGTATCTAAACAG-
30, reverse 50-GGGATGTAGTATGAAGACCACT-30. The ampli-
con was digested with BfaI (New England Biolabs) and the
product was fractionated on an agarose gel which resulted in
three fragments 308, 94 and 59 base pairs in the presence of
insertion; while two fragments of 392 and 59 base pairs were
obtained in the absence of the insertion. 10% of samples
randomly selected but including from all genotypes were re-
genotyped for quality control.
Transient transfection analysis with reporter constructs
Genomic DNA from asthmatic individuals with and without
the 10 base pair insertion was amplified to include 200 base
pairs upstream from the start codon of exon 2. Purified PCR
products were cloned into two different types of vectors: i.
a pGL3 basic vector without a promoter to check for the
promoter activity of the inserted sequence ii. a pGL3
control vector possessing a SV40 promoter region (Promega,
Madison, WI, USA) at Kpn I and Xho I to check for the
enhancer activity of inserted sequence.
A549 bronchial type II alveolar cells (DSMZ, Braunsch-
weig, Germany) were used for the transfection assays. A549
cells were grown to 90% confluence in 24-well plates,
transiently transfected with either promoter reporter
constructs or empty vectors and co-transfected with a pRL-
TK vector (n Z 4) (Promega, Madison, WI, USA) containing
Renilla Luciferase gene using Lipofectamine 2000 (Invi-
trogen, Carlsbad, CA, USA) in accordance with the manu-
facturer’s instructions. 48 h after the transfection, cells
were lysed with reporter lysis buffer and luciferase activity
of each lysate was measured using Dual Luciferase Assay kit
(Promega). Firefly luciferase activity was normalized to
renilla luciferase activity to control for differences in
transfection efficiency.
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared from A549 cells either
without any stimulation or after stimulation with IL-4 (25 ng/
ml for 24 h) (Biosource, Camarillo, CA, USA) and/or IL-13
(25 ng/ml for 24 h) (PeproTech Inc., RockyHill, NJ,USA) using
NE-PER nuclear and cytoplasmic extraction kit (Pierce
Biotechnology, Rockford, IL, USA). Protein concentrations of
nuclear extracts were measured using Bradford Assay (Bio-
Rad, Munich, Germany). Double-stranded, biotin labeled
oligonucleotides (IDT, Coralville, IA, USA) with and without
the insertion were synthesized: without the insertion 50-
AGAACATATAAAAAGCTCTGCGGGACTGGT-30; with the inser-
tion 50-TATAAAAAGCCAATCTAGGCTCTGCGGG- AC-30. Pro-
teineDNA binding reactions were performed with
chemiluminescent LightShift EMSA kit (Pierce Biotech-
nology). Briefly, 2 mg of nuclear protein and 2 pmol of labeled
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50 mM KCl, 1 mM DTT, 2.5% glycerol, 5 mM MgCl2, 50 ng/ml
Poly(dI.dC), 0.05% NP-40 at room temperature for 20 min.
ProteineDNA complexes were resolved on a 6% non-dena-
turing polyacrylamide gel in a TriseborateeEDTA buffer in
a cold room. Complexes were transferred onto a Biodyne
Nylon membrane and cross-linked with UV. Biotin labeled
free oligos and oligo-protein complexes were detected using
streptavidinehorseradish peroxidase system. Gel bands
were visualized using the CDD camera system (Vilber Lour-
mat, Marne-la-Valle´e, France).
Intensity of binding bands was measured by image
analyzer (Syngene Gene Genius, Cambridge, UK) by using
Gene Tools Analaysis Software 3.02.00 (Synoptecs soft-
ware). Intensity of band which represents the binding of
wild type oligos to unstimulated extract was defined as 1
and intensity of other conditions calculated relatively
according to this one’s.
Transcription factor ELISA
Since the insertion sequence contained a CAAT motif for C/
EBP, a custom designed transcription factor ELISA (Active
Motif, Carlsbad, CA, USA) was performed to show the
binding of insertion to C/EBP protein. In this method, the
plates were initially coated with biotin labeled double
stranded oligonucleotides with and without the insertion;
followed by incubation with 5 mg of nuclear extract for 1 h.
The wells were then washed and incubated with a C/EBP
alpha or beta antibody. The reaction was developed with an
anti-IgG HRP conjugate and the colorimetric reaction was
measured using a microplate reader (Molecular Devices,
Sunnyvale, CA, USA) at 450 nm. The experiment was per-
formed in quadruplicate for each condition.Statistical analyses
Statistical analyses were done with SPSS 15 for Windows
(Chicago, IL, USA), Prism 5 for Windows (GraphPad Soft-
ware, Inc. CA, USA) and SAS 9.1 (SAS Institute Inc., Cary,
NC, USA). Comparison of quantitative variables such as age,
eosinophil counts, IgE levels and FEV1% were done with
parametric or non-parametric tests depending on the
normalcy of distribution. In case of non-normal distribu-
tion, non-parametric tests were used only if various trans-
formation methods failed to normalize the data. Chi square
or Fisher’s exact test was used for comparison of categor-
ical variables as appropriate. As expected, there was
a significant difference in the gender distribution between
asthmatic children and healthy controls.26 Therefore, all
data are stratified to account for this gender difference.
For all analyses, a p value <0.05 was considered significant.
We performed linear regression analysis to establish the
factors that were associated with FEV1% and eosinophil
counts. With this regression model, we calculated the
residuals which are the difference between observed
values minus values predicted in the regression. Then, we
constructed a box plot as well as a histogram to see
whether residual distributions are skewed. Both graphs
showed that the distribution of the residuals was not
skewed. In this regression model, our primary endpoint was
the effect of genotype on FEV1% levels or eosinophil counts.We considered the following as covariates in the regression
model: age, gender, age of onset, skin test positivity and
plasma total IgE levels. The model was constructed using
backward elimination. In order to ensure that the
assumptions for linear regression analysis are met, we
checked for the normality of residuals by QeQ plots and
ShapiroeWilk test and in addition we constructed a scatter
plot of residuals versus predicted values.
Results
Five hundred and four children with asthma and 188 healthy
controls were included in the study. Characteristics of
study population are summarized in Table 1. Asthma and
atopyerelated findings including IgE, skin prick tests,
FEV1%, eosinophil counts and family history of allergic
diseases were significantly different between the 2 groups.
Sequencing results
We sequenced 20 asthmatic and 20 healthy controls up to
1 kB in the promoter region and Exon 1 and 2. We iden-
tified 10 SNPs in the promoter and 50UTR region and a 10
base pair insertion (CAATCTAGGC) in the 50UTR region of
exon 2.
Of the 10 SNPs, eight (rs12033184, rs35042265, rs4546919,
rs4554721, rs4442363, rs11102235, rs34698010, rs12026825)
were in complete linkage disequilibrium as shown by
sequencing of 100 DNA samples from each of asthmatic
children and healthy controls. The study population was
genotyped for the presence of only one of these SNPs,
rs4442363 polymorphism, in order to investigate the associ-
ation between this block of SNPs and asthma and asthma
phenotypes.
Of the remaining two SNPs in the promoter region,
sequencing studies of 63 healthy and 80 asthmatic children
showed that there was no genotypic variance in
rs11102234; and that the genotypic distribution of the
rs12023459 was very similar between children with asthma
and healthy controls and failed to show any association
with asthma and atopic phenotypes. Therefore, these two
SNPs were not pursued any further.
Association studies between the promoter SNPs,
asthma diagnosis and asthma phenotypes
Promoter SNPswere analyzed by PCR-RFLP in a subpopulation
of thewholecohort involving352childrenwithasthmaand172
healthy controls. There was no difference in the genotype
distribution of the promoter SNPs between children with
asthma and healthy controls (Table 2). There was no associ-
ationbetween the reportedSNPsandasthmaphenotypes such
as atopy, FEV1%, eosinophil numbers, either.
Association studies between the 50UTR insertion
(CAATCTAGGC), asthma diagnosis and asthma
phenotypes
504 children with asthma and 188 healthy controls were
genotyped for the insertion at 50UTR of exon 2 by PCR-RFLP
Table 1 Characteristic of study population.
Healthy controls
n Z 188
Children with asthma
n Z 504
p
Age (years)a 10.8 (8.0e13.0) 10.0 (7.8e12.7) >0.05
Gender
Male (%) 90 (47.6) 324 (64.5) <0.001
Female (%) 99 (52.4) 179 (35.5)
FEV1 (% predicted)
a 101 (91e108) 92 (79e102) <0.001
Eosinophil count/mm3a 150 (98.9e280.8) 300 (170e500) <0.001
Skin test positivity (%) 29 (15.4) 295 (59.4) <0.001
IgE (kU/L)a 35 (17e72) 178 (55e454) <0.001
Family history of atopic diseases (%) 22 (11.8) 162 (32.3) <0.001
Pet ownership (%) 25 (13.4) 34 (6.8) >0.05
Smoke exposure 106 (57.0) 202 (40.2) >0.05
a Median (Interquartile range).
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cies between children with asthma and healthy controls
(Table 3) showing that this insertion is not associated with
asthma.
Within the asthmatic population, in a model where the
presence of the insertion behaves as the recessive allele
[i.e., wild type þ heterozygotes vs. mutant (insertion
present in both alleles] the insertion was significantly asso-
ciated with lower FEV1% and lower eosinophil counts.
Multiple linear regression analysis showed that the homozy-
gous presence of the insertion was significantly and inde-
pendently associated with lower FEV1% values (bZ 14.63
SEZ 6.241, PZ 0.019). In this model, eosinophil counts had
a small but significant effect, as well (b Z 0.008
SEZ 0.003, PZ 0.003).
The effect of the 10 base pair insertion in the 50UTR
of exon 2 on the expression of AMCase gene
Due to the observed association between insertion and
FEV1%, we attempted to determine the function of the
mutation and tried to establish whether it affects the
expression of AMCase gene using A549 alveolar cell line. In
order to see whether this insertion independently increases
the promoter activity or whether it behaves as an enhancer,
we designed two types of reporter constructs: promoter
type and enhancer type. Cloning of the 200 bp region of
50UTR into a basic vector from both the wild and mutant
genotypes failed to show any difference between the
genotypes (p > 0.05; data not shown). However, cloning of
the same region into a control vector just in front of the
SV40 promoter as an enhancer element showed that the
sequence with the insertion displayed significantly higher
luciferase activity compared to the wild type (p < 0.05)Table 2 Genotype frequencies of the promoter polymorphism
Genotype Healthy Controls n Z 172 n (%)
CC 59 (34.3)
CT 78 (45.3)
TT 35 (20.3)(Fig. 1). Stimulation of A549 cells with IL-4, IL-13 or both
further increased the enhancer activity conferred by the
presence of the insertion (Fig. 1). The results of this
experiment suggested that the studied insertion behaves as
an enhancer element for the AMCase gene and that this
enhancer activity increases in the presence of IL-4.
The effect of the 10 base pair insertion in the 50UTR
on nuclear protein avidity and specific binding of C/
EBP
Electrophoretic mobility shift assay (EMSA) was performed
with nuclear extracts obtained from A549 cells with and
without stimulation with IL-4 and IL-13. The EMSA assay
showed more intensive bands with the mutant probe pos-
sessing the insertion suggesting stronger binding affinity of
the mutant sequence with the insertion to the nuclear
extracts (Fig. 2).
In order to identify the transcription factor that is
responsible for higher binding avidity of the mutant probe,
we performed supershift experiments with antibodies to
various transcription factors. Our main candidate was the
transcription factor C/EBP (CAAT enhancer binding protein)
as the inserted sequence contains a CAAT motif for C/EBP
binding. However, antibodies to C/EBP failed to induce any
supershift (Fig. 2). We were unable to induce any supershift
with antibodies to other transcription factors such as Oct-1
and GATA-3 (data not shown).
Since EMSA assay failed to show whether C/EBP is the
transcription factor responsible for the specific binding,
a more sensitive TransAM transcription factor ELISA was
performed. Plates were covered with biotin labeled double
stranded wild type and mutant type oligonucleotides; incu-
batedwith nuclear extracts andC/EBPa orb antibodieswerers4442363 in the AMCase gene.
Children with asthma n Z 352 n (%) P
97 (27.6)
190 (54.0)
65 (18.5) >0.05
Table 3 Genotype frequencies of 10 the base pair insertion in the 50UTR region of exon 2
Genotype Healthy controls n Z 188 n (%) Children with asthma n Z 504 n (%) p
Wild type (no insertion) 153 (84.1) 409 (81.2)
Heterozygote 33 (17.6) 87 (17.3)
Mutant (insertion present in both alleles) 2 (1.1) 8 (1.6) >0.05
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C/EBP b but not to a showed specific binding. Fig. 3 shows
that stimulation with IL-4 significantly reduced binding of
C/EBP b to nuclear extracts (p Z 0.002) but there was no
difference in the binding avidity between the oligonucleo-
tideswith orwithout the insertion. Further experimentswith
GATA family transcription factors including GATA-1, 2 and 3
failed to show any difference between the two genotypes.Genotyping of the adult population
In order to confirm our findings in another population, we
genotyped 317 patients with mild and 145 patients with
severe asthma for the presence of the insertion (Table 4).
The severe asthmatics were older and had lower lung
function than the mild asthmatics. There was no difference
in the frequency of the insertion between the two groups.
In contrast to our observation in the pediatric population,
adults with the homozygous form of insertion had showed
a trend toward higher FEV1% values that approached
significance [90.4  4.6% in mutant (insertion present in
both alleles) vs 81.2  0.9 in wild type þ heterozygotes,
p Z 0.06]. Because of our adult population composed ofFigure 1 Promoter reporter assay. A549 cells were tran-
siently transfected with wild type reporter vector (WV) or
mutant type reporter vector (MV). Reporter activity was
normalized relative to the activity of pGL3 control vector. No
promoter activity was observed after transfection with the
basic vector, therefore only the results of transfection with the
control vector are shown. Reporter activity was significantly
higher in A549 cells transiently transfected with control
reporter vector containing the ten base pair insertion than the
constructs bearing the wild type allele. (BV Z pGL3 Basic
vector without a promoter, CV Z pGL3 control vector with
a SV40 promoter).different ethnic backgrounds population stratification was
assessed, but not significant differences was found
between groups.Discussion
There is a great deal of controversy surrounding the phys-
iological effects of chitinase proteins as well as the effects
of the variants of the encoding genes in asthma. In this
report, we show that a genetic variant in the second exon
of the AMCase gene may modify the function of the gene
and the same variant may have different and even opposite
effects in two different populations.
In their initial report, Zhu et al. have shown that AMCase
is expressed in the asthmatic lung and is found in the BAL
fluid of asthmatics.11 They have also shown that it acts
downstream of IL-13 in the inflammatory pathway. These
results were challenged in a mouse model where AMCase
was shown to inhibit chitin induced eosinophil and basophil
recruitment to the lungs suggesting that AMCase can
prevent allergic response induced by chitin. In a human
study Seibold et al.16 showed that chitinase activity in BAL
samples was mostly related to chitotriosidase (CHIT1) but
not to AMCase. More importantly, they showed that chiti-
nase activity was not higher, but actually lower in BAL fluids
of asthmatics than control subjects and was increased in
habitual smokers. Similar to the controversies regarding the
function of chitinase, there have been conflicting reports
on the effect of AMCase genotypes on asthma and asthma
related phenotypes, as well.
We attempted to search for the genetic variants of the
AMCase gene that may modify the disease expression and
thus may affect the severity of asthma. We found that an
insertion containing a CAAT motif (CAATCTAGGC) in the
50UTR region of exon 2 was associated with lower FEV1% in
children with asthma. In a reporter gene system, we also
showed that this variant enhances the promoter activity of
the gene especially in the presence of IL-4. Further to this
observation, EMSA studies revealed that the sequence with
the insertion binds the nuclear extracts containing the
regulatory proteins with higher avidity compared to the
wild type oligonucleotides that does not carry the insertion.
Although C/EBP beta binds to the region containing the
inserted sequence, the nuclear factor ELISA study showed
that the presence or absence of the insertion does not
change the binding, suggesting that C/EBP is not the tran-
scription factor responsible for the enhancer activity of the
insertion sequence. Interestingly, in contrast to our obser-
vation in the reporter system, IL-4 decreased the binding of
C/EBP beta in the ELISA experiment. Collectively, these
data implicate that the differential binding of other tran-
scription factor (or factors) may be responsible for the
action of this inserted 10 base pair sequence. These factors
Figure 2 EMSA experiment. Nuclear proteins from A549 cells, unstimulated or stimulated with IL-4 and IL-13, bind to the probes
carrying the insertion sequence (M) with more avidity than those probes without the insertion (W). Antibody to C/EBP-b failed to
induce a supershift.
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functional analyses are carried out in A549 cells which
belong to an alveolar cell line. Even though A549 cells have
been used in numerous studies to investigate various
pathological and physiological aspects of lung diseases,27
they do not truly represent the cells of the airways which
are the major players in lung function. Therefore, even
though we describe functions related to this insertion, we
do not know whether expression of this gene is actually
related to the phenotype of lung function.
In addition to our study, four studies have previously
investigated the association between the genotypic variant
of the AMCase gene and asthma. The promoter SNPs that
we report here have previously been reported by BierbaumFigure 3 Custom designed C/EBP transcription factor ELISA.
Plates are initially coated with biotin labeled double stranded
oligos with and without the insertion followed by incubation
nuclear extracts obtained from A549 cells. Optical density is
measured after incubation with C/EBP beta antibody. Empty
bars represent wild type probes without the insertion and black
bars represent mutant probes with the insertion.et al.17 They also failed to show any association between
these SNPs and asthma phenotypes in German children.
Chatterjee et al.19 on the other hand, have reported
significant associations with 2 SNPs in the part of the
promoter that goes 1000 bp further up to the 50 region that
was selected in our study. One of these SNPs rs3806448 is
associated both with asthma and IgE in the Indo-Aryan
population. This particular SNP was in linkage disequilib-
rium with the SNPs used in our study. Therefore, one can
assume that we would have failed to find an association
with this SNP even if we had done our analysis to include
that far in the 50 of the promoter. To further support the
discrepancy, Wu et al.20 also failed to find any association
with rs3806448 in a North American population of asthmatic
children. Similarly, rs10494132 was found to be associated
with IgE by Chatterjee et al. but not by Wu et al. In fact, Wu
et al., in a comprehensive analysis, failed to show any
association between asthma and any of the 24 SNPs in the
AMCase gene that they studied.
The insertion that we report in our study was only
detected in a recent study by Seibold et al.18 in a pop-
ulation of African American, Puerto Rican, and Mexicans.
However, they did not report any association with this
particular SNP. In our study, we report two discrepant
findings in two different populations. In a population of
Turkish asthmatic children we found that the presence of
insertion was associated with lower FEV1%, a finding which
was supported by the results of the logistic regression
analysis that showed that the insertion was in fact signifi-
cantly and independently associated with lower FEV1%. In
a North American population composed of mild and severe
asthmatics, the same analysis has showed that the same
insertion was associated with higher FEV1%.
Our study may be criticized for attempting to replicate
the findings from a pediatric population in a population
composed of adults. Since the presence of insertion was
associated with lower FEV1 in the pediatric group, we
Table 4 Characteristics of the adult population with asthma.
Mild asthma n Z 317 n (%) Severe asthma n Z 145 n (%) P
Age (years)a 30 (0.57) 44 (1.12) < 0.0001
Gender
Male 114 (36) 56 (39)
Female 203 (64) 89 (61) >0.05
Race
Caucasian 215 (68) 86 (59)
African American 65 (20) 43 (30)
Asian 10 (3) 7 (5)
Other/Mixed 27 (9) 9 (6) >0.05
Ethnicity
Hispanic 25 (8) 10 (7)
Non-Hispanic 292 (92) 135 (93) >0.05
FEV1 (% predicted)
a 90 (0.80) 64 (1.33) < 0.0001
ICS use 28 (9) 145 (100) < 0.0001
Genotypeb
Wild 237 (75) 108 (75)
Heterozygote 68 (21) 33 (23)
Mutant 12 (4) 3 (2) >0.05
a Mean (Standard error of the mean).
b Genotype frequencies of 10 the base pair insertion in the 50UTR region of exon 2.
Chitinase polymorphisms in asthma 1167hypothesized that it may be associated with the severity of
the disease as lower FEV1 is a major determinant of asthma
severity. However, severe asthma is quite rare in children.
Therefore, in order to obtain a robust finding regarding the
association of the SNP with asthma severity we chose an
adult population containing a significant number of patients
with severe asthma.
There are two major differences between our initial and
replication cohorts: they are of different genetic back-
grounds and they are of different age groups. There may be
several reasons to account for the discrepant results
reported in the literature and here. One explanation would
be differences in the genetic backgrounds of the pop-
ulations studied. The presence of polymorphisms in the
other regions of the AMCase gene or variants in other genes
causing epistatic effects may also be operative in under-
lying the differences.
In addition to age and ethnic differences, another factor
could be the differences in the environmental exposures as
several studies have shown that the response of the genes
can vary significantly depending on the environmental
exposures. In one of the best examples of the gene environ-
ment interaction, when the results of the asthma and
endotoxin study were stratified according to the endotoxin
exposure it was shown that the C allele of the CD14-159 C/T
SNPwas associated with a higher risk of allergic sensitization
at low levels of endotoxin exposure and lower risk at high
levels of exposure.28,29 This observation was later substan-
tiated by two independent studies.30,31 In the in-vitro envi-
ronment, we have shown that the two genotypes respond
differently to increasing concentrations of endotoxin.32
Therefore, there is reason to believe that the effects of the
genetic variants may vary significantly depending on the
environmental chitin exposure, as well. To make the issue
even more complicated, a recent study by Wu et al. have
shown that high mold exposure significantly modified the
relation between 3 SNPs in CHIT1 (rs2486953, rs4950936,rs1417149) and severe exacerbations, even though the same
SNPs showed no association in their original study where the
environmental exposures have not been taken into
account.33 This observation suggests that the association
between the chitinase genes and environmental exposure
can go even beyond environmental chitin exposure and may
be influenced by mold exposure, as well.
A third factor to account for the discrepant results
between the two populations of this study can be the age of
the studied populations. Expression patterns of genes may
be under epigenetic influences and thus may change with
age. Recently, Munthe-Kaas et al. have shown that CD14
methylation increased significantly from age 2e10 years,
and that the level of methylation was inversely correlated
with sCD14 levels at 10 years.34 They have also shown that
even though 3 SNPs were associated with sCD14 levels
within the first two years of life, only one was associated at
10 years. Therefore, the differences that we observed
between the two populations, one pediatric and the other
adult, can be partially due to the differences in the age of
the study cohorts and be modified by epigenetic factors.
Finally, as we have extensively discussed, the two pop-
ulations are different with respect to many variables
including their ethnic backgrounds and environmental
exposures. Even though we have chosen an adult pop-
ulation of patients with severe asthma in order to obtain
a robust finding regarding the association of the SNP with
asthma severity, it would definitely be desirable and
increase the strength of our findings if we could do the
same comparison in a well matched pediatric population
with severe asthma.
Our study has weaknesses. Firstly, it would be extremely
helpful to have the measures of the environmental chitin
exposure or, in light of recent studies, mold exposure levels
of our population. Secondly, even though we have shown
that the insertion increases the expression of the reporter
gene, we do not have any evidence that it changes the
1168 E. Birben et al.protein levels in the lungs of the asthmatics and that it is
directly associated with measures of lung function. Simi-
larly, we do not have evidence that it affects the tissue
levels of infiltrating eosinophils.
To conclude, our study shows that a ten base pair
insertion in the second exon in the 50UTR region of the
AMCase gene may modify the gene expression and thus may
affect the severity of asthma. However, its effects may be
different in different populations and may be modified by
various environmental exposures and demographics of the
population under study.
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